title: [Living related liver transplantation - analysis of the first 102 cases].
abstract: OBJECTIVE
  of the study was to analyse the first 102 living-related liver transplantations performed in Poland at the Children's Memorial Health Institute.
  
  
  METHODS
  between November 1999 and January 2007 102 living-related liver transplantations were carried out in 101 patients. In 63 the patients the indication for liver transplantation was biliary atresia, in 7 - intrahepatic cholestasis, in 11 - acute liver failure, in 9 - hepatic tumour, in two - graft insufficiency. The remaining indications included hepatic cirrosis in course of cystic fibrosis, Caroli disease and biliary cysts. There were 61 girls and 40 boys aged from 4 months to 11 years (mean 2.5 years). The body weight ranged from 4.5 to 31 kg (mean 12 kg).
  
  
  RESULTS
  eighty seven children are alive (86%). Five died in the early posttranplant period (between 2 and 11 days after operation), 9 died in the later period (from 36 days to 5 years and 10 months after the operation). The most serious, life threatening early and late complications were bacterial infections. The most frequent scheme of immunosuppressive treatment was tacrolimus and corticosteroids (64%) and tacrolimus and mycophenolate mofetil (16%).
  
  
  CONCLUSIONS
  living-related liver transplantation is an effective method of treatment of acute and end-stage liver diseases in children with low body mass.
authors.affiliation: Klinika Gastroenterologii, Hepatologii i Immunologii, Instytut Pomnik Centrum Zdrowia Dziecka, Al. Dzieci Polskich 20, 04-730 Warszawa, Poland. liver@czd.pl
authors.forename: Joanna
authors.initials: J
authors.lastname: Pawłowska
authors.forename: Piotr
authors.initials: P
authors.lastname: Kaliciński
authors.forename: Irena
authors.initials: I
authors.lastname: Jankowska
authors.forename: Mikołaj
authors.initials: M
authors.lastname: Teisseyre
authors.forename: Joanna
authors.initials: J
authors.lastname: Teisseyre
authors.forename: Diana
authors.initials: D
authors.lastname: Kamińska
authors.forename: Paweł
authors.initials: P
authors.lastname: Nachulewicz
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Markiewicz-Kijewska
authors.forename: Jerzy
authors.initials: J
authors.lastname: Socha
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007223:Infant; D017114:Liver Failure, Acute / Q000175:diagnosis / Q000401:mortality* / Q000601:surgery*; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D019520:Living Donors / Q000706:statistics & numerical data*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011044:Poland; D011183:Postoperative Complications / Q000401:mortality; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D009173:Mycophenolic Acid; D016559:Tacrolimus